MCRB
NASDAQ · Biotechnology
Seres Therapeutics Inc
$7.89
+0.10 (+1.28%)
Open$7.78
Previous Close$7.79
Day High$8.00
Day Low$7.60
52W High$29.98
52W Low$5.31
Volume—
Avg Volume100.4K
Market Cap67.93M
P/E Ratio—
EPS$-5.08
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+226.1% upside
Current
$7.89
$7.89
Target
$25.73
$25.73
$18.91
$25.73 avg
$33.51
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 914.7K | 3.22M | 47.44M |
| Net Income | 6.60M | 20.93M | 5.52M |
| Profit Margin | 721.9% | 685.8% | 11.6% |
| EBITDA | -10,605,120 | -35,499,873 | 8.75M |
| Free Cash Flow | — | — | 3.59M |
| Rev Growth | -71.6% | -71.6% | +12.6% |
| Debt/Equity | — | — | 0.48 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |